Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1985 Jan;44(1):50–53. doi: 10.1136/ard.44.1.50

HLA antigens and seronegative rheumatoid arthritis.

T Bardin, L Legrand, B Naveau, A Marcelli-Barge, N Debeyre, G M Lathrop, J C Poirier, M Schmid, A Ryckewaert, A Dryll
PMCID: PMC1001567  PMID: 3855618

Abstract

HLA antigens and clinical features in a series of 46 Caucasian patients (40 females, 6 males) and definite repeatedly seronegative rheumatoid arthritis (RA) of more than two years' duration (mean 11.6 years) were compared with those in 77 seropositive RA patients and 110 controls of the same ethnic and geographic origin. Seronegative RA appeared to be less often erosive than seropositive RA, and seronegative patients had fewer extra-articular features. The frequency of the HLA antigen DR1 was raised in seronegative patients as compared with controls (p = 0.006, relative risk = 3) and with seropositive patients (p less than 0.05). HLA-DR4 was slightly increased in seronegative patients compared with controls (p less than 0.05) but was clearly less so than in seropositive patients (p less than 0.005). Early onset of disease was very significantly associated with HLA-DR1 in seronegative patients (p = 0.007), whereas HLA-DR4 was present more frequently in seropositive patients with onset prior to age 35 (p less than 0.05). No correlation between HLA antigens and intolerance to drugs was found in seronegative patients, whereas in seropositive patients side effects to gold salts were associated with DR3. These results suggest that seropositive and seronegative RA have distinct HLA-DR associations, especially in disease of early onset, in addition to well established clinical differences.

Full text

PDF
50

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alarcón G. S., Koopman W. J., Acton R. T., Barger B. O. DR antigen distribution in Blacks with rheumatoid arthritis. J Rheumatol. 1983 Aug;10(4):579–583. [PubMed] [Google Scholar]
  2. Alarcón G. S., Koopman W. J., Acton R. T., Barger B. O. Seronegative rheumatoid arthritis. A distinct immunogenetic disease? Arthritis Rheum. 1982 May;25(5):502–507. doi: 10.1002/art.1780250503. [DOI] [PubMed] [Google Scholar]
  3. Bardin T., Dryll A., Debeyre N., Peltier A. P., Ryckewaert A. Les polyarthrites rhumatoïdes avec anticorps antinucléaires. Etude prospective sur 50 cas personnels. Nouv Presse Med. 1982 Feb 13;11(7):501–504. [PubMed] [Google Scholar]
  4. Bardin T., Dryll A., Debeyre N., Ryckewaert A., Legrand L., Marcelli A., Dausset J. HLA system and side effects of gold salts and D-penicillamine treatment of rheumatoid arthritis. Ann Rheum Dis. 1982 Dec;41(6):599–601. doi: 10.1136/ard.41.6.599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bardin T., Dryll A., Debeyre N., Ryckewaert A. Polyarthrite rhumatoïde et système HLA. Recherche d'une corrélation entre les antigènes d'histocompatibilité et les caractéristiques de la maladie. Nouv Presse Med. 1982 Sep 25;11(37):2753–2756. [PubMed] [Google Scholar]
  6. Cats A., Hazevoet H. M. Significance of positive tests for rheumatoid factor in the prognosis of rheumatoid arthritis. A follow-up study. Ann Rheum Dis. 1970 May;29(3):254–260. doi: 10.1136/ard.29.3.254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. DUTHIE J. J., BROWN P. E., TRUELOVE L. H., BARAGAR F. D., LAWRIE A. J. COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT. Ann Rheum Dis. 1964 May;23:193–204. doi: 10.1136/ard.23.3.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dobloug J. H., Førre O., Kåss E., Thorsby E. HLA antigens and rheumatoid arthritis. Association between HLA-DRw4 positivity and IgM rheumatoid factor production. Arthritis Rheum. 1980 Mar;23(3):309–313. doi: 10.1002/art.1780230307. [DOI] [PubMed] [Google Scholar]
  9. Edelman J., Russell A. S. A comparison of patients with seropositive and seronegative rheumatoid arthritis. Rheumatol Int. 1983;3(1):47–48. doi: 10.1007/BF00541233. [DOI] [PubMed] [Google Scholar]
  10. Gordon D. A., Stein J. L., Broder I. The extra-articular features of rheumatoid arthritis. A systematic analysis of 127 cases. Am J Med. 1973 Apr;54(4):445–452. doi: 10.1016/0002-9343(73)90040-5. [DOI] [PubMed] [Google Scholar]
  11. Gran J. T., Husby G., Thorsby E. HLA DR antigens and gold toxicity. Ann Rheum Dis. 1983 Feb;42(1):63–66. doi: 10.1136/ard.42.1.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gran J. T., Husby G., Thorsby E. The association between rheumatoid arthritis and the HLA antigen DR4. Ann Rheum Dis. 1983 Jun;42(3):292–296. doi: 10.1136/ard.42.3.292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Karr R. W., Rodey G. E., Lee T., Schwartz B. D. Association of HLA-DRw4 with rheumatoid arthritis in black and white patients. Arthritis Rheum. 1980 Nov;23(11):1241–1245. doi: 10.1002/art.1780231102. [DOI] [PubMed] [Google Scholar]
  14. Legrand L., Lathrop G. M., Marcelli-Barge A., Dryll A., Bardin T., Debeyre N., Poirier J. C., Schmid M., Ryckewaert A., Dausset J. HLA-DR genotype risks in seropositive rheumatoid arthritis. Am J Hum Genet. 1984 May;36(3):690–699. [PMC free article] [PubMed] [Google Scholar]
  15. Maeda H., Juji T., Mitsui H., Sonozaki H., Okitsu K. HLA DR4 and rheumatoid arthritis in Japanese people. Ann Rheum Dis. 1981 Jun;40(3):299–302. doi: 10.1136/ard.40.3.299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Mittal K. K., Mickey M. R., Singal D. P., Terasaki P. I. Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation. 1968 Nov;6(8):913–927. doi: 10.1097/00007890-196811000-00006. [DOI] [PubMed] [Google Scholar]
  17. Panayi G. S., Wooley P., Batchelor J. R. Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs. Br Med J. 1978 Nov 11;2(6148):1326–1328. doi: 10.1136/bmj.2.6148.1326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. RAGAN C. The clinical features of rheumatoid arthritis. Prognostic indices. JAMA. 1962 Aug 25;181:663–667. doi: 10.1001/jama.1962.03050340001001. [DOI] [PubMed] [Google Scholar]
  19. ROPES M. W., BENNETT G. A., COBB S., JACOX R., JESSAR R. A. 1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis. 1958 Dec;9(4):175–176. [PubMed] [Google Scholar]
  20. Scherak O., Smolen J. S., Mayr W. R. HLA-DR antigens and disease patterns of rheumatoid arthritis. Rheumatol Int. 1983;3(3):113–116. doi: 10.1007/BF00541190. [DOI] [PubMed] [Google Scholar]
  21. Schiff B., Mizrachi Y., Orgad S., Yaron M., Gazit E. Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis. Ann Rheum Dis. 1982 Aug;41(4):403–404. doi: 10.1136/ard.41.4.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Speerstra F., Reekers P., van de Putte L. B., Vandenbroucke J. P., Rasker J. J., de Rooij D. J. HLA-DR antigens and proteinuria induced by aurothioglucose and D-penicillamine in patients with rheumatoid arthritis. J Rheumatol. 1983 Dec;10(6):948–953. [PubMed] [Google Scholar]
  23. Willkens R. F., Hansen J. A., Malmgren J. A., Nisperos B., Mickelson E. M., Watson M. A. HLA antigens in Yakima Indians with rheumatoid arthritis. Lack of association with HLA-Dw4 and HLA-DR4. Arthritis Rheum. 1982 Dec;25(12):1435–1439. doi: 10.1002/art.1780251208. [DOI] [PubMed] [Google Scholar]
  24. Woodrow J. C., Nichol F. E., Zaphiropoulos G. DR antigens and rheumatoid arthritis: a study of two populations. Br Med J (Clin Res Ed) 1981 Nov 14;283(6302):1287–1288. doi: 10.1136/bmj.283.6302.1287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Wooley P. H., Griffin J., Panayi G. S., Batchelor J. R., Welsh K. I., Gibson T. J. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis. N Engl J Med. 1980 Aug 7;303(6):300–302. doi: 10.1056/NEJM198008073030602. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES